ZNF727
gene geneOn this page
Summary
ZNF727 (zinc finger protein 727, HGNC:22785) is a protein-coding gene on chromosome 7q11.21, encoding Zinc finger protein 727 (A8MUV8). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in nucleus.
Source: NCBI Gene 442319 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 85 total
- MANE Select transcript:
NM_001159522
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:22785 |
| Approved symbol | ZNF727 |
| Name | zinc finger protein 727 |
| Location | 7q11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000214652 |
| Ensembl biotype | protein_coding |
| Entrez | 442319 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000456806, ENST00000715348, ENST00000889950, ENST00000889951
RefSeq mRNA: 1 — MANE Select: NM_001159522
NM_001159522
CCDS: CCDS55113
Canonical transcript exons
ENST00000456806 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001618685 | 64077276 | 64085339 |
| ENSE00003499424 | 64069514 | 64069609 |
| ENSE00003676945 | 64068891 | 64069017 |
| ENSE00004026571 | 64045434 | 64045624 |
Expression profiles
Bgee: expression breadth ubiquitous, 209 present calls, max score 84.77.
FANTOM5 (CAGE): breadth broad, TPM avg 2.6179 / max 180.7664, expressed in 321 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 78790 | 2.6179 | 321 |
Top tissues by expression
245 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oviduct epithelium | UBERON:0004804 | 84.77 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 82.41 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.75 | gold quality |
| endothelial cell | CL:0000115 | 78.90 | gold quality |
| secondary oocyte | CL:0000655 | 78.87 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.18 | gold quality |
| corpus epididymis | UBERON:0004359 | 78.11 | gold quality |
| buccal mucosa cell | CL:0002336 | 76.05 | silver quality |
| mammary duct | UBERON:0001765 | 75.28 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 75.13 | gold quality |
| caput epididymis | UBERON:0004358 | 74.27 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 73.13 | gold quality |
| mammary gland | UBERON:0001911 | 73.01 | gold quality |
| parietal pleura | UBERON:0002400 | 72.86 | gold quality |
| entorhinal cortex | UBERON:0002728 | 71.09 | gold quality |
| postcentral gyrus | UBERON:0002581 | 70.68 | gold quality |
| bronchial epithelial cell | CL:0002328 | 70.18 | gold quality |
| ovary | UBERON:0000992 | 70.14 | gold quality |
| cauda epididymis | UBERON:0004360 | 69.92 | gold quality |
| skin of hip | UBERON:0001554 | 69.73 | gold quality |
| tibia | UBERON:0000979 | 69.67 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 69.01 | gold quality |
| bronchus | UBERON:0002185 | 68.83 | gold quality |
| visceral pleura | UBERON:0002401 | 68.80 | gold quality |
| fallopian tube | UBERON:0003889 | 68.63 | gold quality |
| left ovary | UBERON:0002119 | 68.51 | gold quality |
| islet of Langerhans | UBERON:0000006 | 68.11 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 67.69 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 67.27 | gold quality |
| parietal lobe | UBERON:0001872 | 66.75 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 5.47 |
Regulation
Is transcription factor: no
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp738 | ENSMUSG00000048280 |
| mus_musculus | Zfp457 | ENSMUSG00000055341 |
| mus_musculus | Zfp595 | ENSMUSG00000057842 |
| mus_musculus | Zfp953 | ENSMUSG00000098905 |
| rattus_norvegicus | AABR07009105.1 | ENSRNOG00000053325 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 727 — A8MUV8 (reviewed: A8MUV8)
All UniProt accessions (1): A8MUV8
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_001152994* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050527 |
Pfam: PF00096, PF01352, PF13894
UniProt features (13 total): zinc finger region 11, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A8MUV8-F1 | 70.12 | 0.16 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 20 (showing top):
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN, chr7q11, GOCC_NUCLEOLUS, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, OUILLETTE_CLL_13Q14_DELETION_DN, THUM_SYSTOLIC_HEART_FAILURE_UP, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, PULVER_FOREY_PERTURB_ACCUMULATION_G2_M, PULVER_FOREY_PERTURB_ATTRITION_M_EG1, KORKOLA_CORRELATED_WITH_POU5F1, GOMF_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING
GO Biological Process (2): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), double-stranded DNA binding (GO:0003690), metal ion binding (GO:0046872)
GO Cellular Component (3): nucleolus (GO:0005730), microtubule cytoskeleton (GO:0015630), nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of transcription by RNA polymerase II | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| DNA binding | 1 |
| cation binding | 1 |
| nuclear lumen | 1 |
| intracellular membraneless organelle | 1 |
| cytoskeleton | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
148 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF727 | CFAP68 | Q9H5F2 | 576 |
| ZNF727 | C16orf87 | Q6PH81 | 571 |
| ZNF727 | DEFB115 | Q30KQ5 | 507 |
| ZNF727 | FAM135A | Q9P2D6 | 434 |
| ZNF727 | ANKRD9 | Q96BM1 | 419 |
| ZNF727 | ASB7 | Q9H672 | 391 |
| ZNF727 | TSPAN17 | Q96FV3 | 380 |
| ZNF727 | RBBP4 | P31149 | 375 |
| ZNF727 | NFXL1 | Q6ZNB6 | 374 |
| ZNF727 | ZGPAT | Q8N5A5 | 370 |
| ZNF727 | SEC14L6 | B5MCN3 | 370 |
| ZNF727 | TRIM52 | Q96A61 | 356 |
| ZNF727 | TMEM163 | Q8TC26 | 348 |
| ZNF727 | RNF144A | P50876 | 348 |
| ZNF727 | UBR7 | Q8N806 | 338 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF727 | ECE1 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (3): ZNF727 (Affinity Capture-MS), ZNF727 (Affinity Capture-MS), CALR (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A6NK75, A6NNF4, A6NP11, A8MTY0, A8MUV8, B4DXR9, C9JN71, O75346, O75373, O95780, P0CJ79, P0DKX0, P0DPD5, P17019, P17035, P35789, Q03923, Q03938, Q08AN1, Q14593, Q15928, Q3SXZ3, Q3ZCX4, Q5MCW4, Q5R9S5, Q5RER9, Q68DY1, Q6JLC9, Q6ZMV8, Q6ZN06, Q6ZN08, Q6ZNA1, Q76KX8, Q86T29, Q86V71, Q8IYN0, Q8N4W9, Q8N7M2, Q8NEM1, Q8TD23
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
85 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 71 |
| Likely benign | 5 |
| Benign | 5 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
753 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:64045623:TGGTG:T | donor_loss | 1.0000 |
| 7:64045624:GGTG:G | donor_loss | 1.0000 |
| 7:64045625:G:T | donor_loss | 1.0000 |
| 7:64045626:T:G | donor_loss | 1.0000 |
| 7:64057454:G:GT | donor_gain | 1.0000 |
| 7:64068890:GCGA:G | acceptor_gain | 1.0000 |
| 7:64045625:G:GG | donor_gain | 0.9900 |
| 7:64045627:GAGT:G | donor_loss | 0.9900 |
| 7:64068321:A:T | donor_gain | 0.9900 |
| 7:64068885:TTTCA:T | acceptor_loss | 0.9900 |
| 7:64068888:CA:C | acceptor_loss | 0.9900 |
| 7:64068889:A:AG | acceptor_gain | 0.9900 |
| 7:64068889:AGC:A | acceptor_gain | 0.9900 |
| 7:64068890:G:GG | acceptor_gain | 0.9900 |
| 7:64068890:G:GT | acceptor_loss | 0.9900 |
| 7:64068890:GC:G | acceptor_gain | 0.9900 |
| 7:64068890:GCG:G | acceptor_gain | 0.9900 |
| 7:64069016:GG:G | donor_gain | 0.9900 |
| 7:64069016:GGGTG:G | donor_loss | 0.9900 |
| 7:64069017:GG:G | donor_gain | 0.9900 |
| 7:64069018:G:GG | donor_gain | 0.9900 |
| 7:64069018:GT:G | donor_loss | 0.9900 |
| 7:64069019:T:G | donor_loss | 0.9900 |
| 7:64069020:GAGAA:G | donor_loss | 0.9900 |
| 7:64077270:TTTCA:T | acceptor_loss | 0.9900 |
| 7:64077272:TCA:T | acceptor_loss | 0.9900 |
| 7:64077273:CAG:C | acceptor_loss | 0.9900 |
| 7:64077274:A:AG | acceptor_gain | 0.9900 |
| 7:64077274:AGCT:A | acceptor_gain | 0.9900 |
| 7:64077274:AGCTG:A | acceptor_gain | 0.9900 |
AlphaMissense
3332 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:64078094:T:C | F349L | 0.994 |
| 7:64078096:T:A | F349L | 0.994 |
| 7:64078096:T:G | F349L | 0.994 |
| 7:64077842:T:C | F265L | 0.993 |
| 7:64077844:T:A | F265L | 0.993 |
| 7:64077844:T:G | F265L | 0.993 |
| 7:64078262:T:C | F405L | 0.993 |
| 7:64078264:T:A | F405L | 0.993 |
| 7:64078264:T:G | F405L | 0.993 |
| 7:64077926:T:C | F293L | 0.991 |
| 7:64077928:T:A | F293L | 0.991 |
| 7:64077928:T:G | F293L | 0.991 |
| 7:64078178:T:C | F377L | 0.991 |
| 7:64078180:T:A | F377L | 0.991 |
| 7:64078180:T:G | F377L | 0.991 |
| 7:64078346:T:C | F433L | 0.991 |
| 7:64078348:T:A | F433L | 0.991 |
| 7:64078348:T:G | F433L | 0.991 |
| 7:64078430:T:C | F461L | 0.990 |
| 7:64078432:T:A | F461L | 0.990 |
| 7:64078432:T:G | F461L | 0.990 |
| 7:64078010:T:C | F321L | 0.989 |
| 7:64078012:T:A | F321L | 0.989 |
| 7:64078012:T:G | F321L | 0.989 |
| 7:64078197:T:C | L383P | 0.988 |
| 7:64078205:C:G | H386D | 0.985 |
| 7:64078207:T:A | H386Q | 0.984 |
| 7:64078207:T:G | H386Q | 0.984 |
| 7:64078219:C:A | H390Q | 0.984 |
| 7:64078219:C:G | H390Q | 0.984 |
dbSNP variants (sampled 300 via entrez): RS1000097312 (7:64073496 A>G), RS1000258034 (7:64073308 T>TG), RS1000288701 (7:64049660 G>A), RS1000415597 (7:64043955 G>A), RS1000549975 (7:64062696 A>G), RS1000680166 (7:64049964 A>G), RS1000901646 (7:64062965 A>G), RS1000919954 (7:64081918 G>A), RS1000983967 (7:64068759 C>G), RS1001190993 (7:64052321 G>A), RS1001261129 (7:64073925 G>A), RS1001286348 (7:64061924 A>T), RS1001374589 (7:64081618 A>G), RS1001448405 (7:64068436 G>T), RS1001499057 (7:64075071 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| TAK-243 | increases sumoylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.